登录 注册 会员服务 联系我们

Longer-Term Effectiveness and Tolerability of Adjunctive Open Lurasidone in Patients With Bipolar Disorder

  • Published:2018-06 Issue:3 Volume:38 Page:207-211
  • ISSN:1533-712X
  • Container-title:Journal of Clinical Psychopharmacology
  • language:en
  • Short-container-title:J Clin Psychopharmacol

Author:

Miller Shefali,Do Dennis,Gershon Anda,Wang Po W.,Hooshmand Farnaz,Chang Lauren S.,Ketter Terence A.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference20 articles.

1. Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication;Arch Gen Psychiatry,2007

2. The prevalence and burden of bipolar depression;J Affect Disord,2014

3. Bipolar therapeutics update 2014: a tale of 3 treatments;J Clin Psychiatry,2015

4. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed;J Affect Disord,2014

5. Lurasidone in the treatment of bipolar depression: systematic review of systematic reviews;Biomed Res Int,2017
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3